Vertex Pharmaceuticals (VRTX) News Today $440.87 -7.53 (-1.68%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$441.24 +0.38 (+0.09%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VRTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Vertex Pharmaceuticals Inc (VRTX) Unveils Promising Data from Zimislecel Clinical Trial for ...June 21 at 5:49 PM | gurufocus.comGAM Holding AG Grows Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)GAM Holding AG increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,045 shares of the pharmaceutical company's stocJune 21 at 6:24 AM | marketbeat.comAvior Wealth Management LLC Has $1.12 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Avior Wealth Management LLC lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 22.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,302 shares of the pharmaceutical coJune 21 at 5:04 AM | marketbeat.comRetirement Systems of Alabama Lowers Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Retirement Systems of Alabama cut its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,18June 21 at 4:48 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Envestnet Portfolio Solutions Inc.Envestnet Portfolio Solutions Inc. lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,022 shares of the pharJune 21 at 4:23 AM | marketbeat.comWealth Enhancement Advisory Services LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Wealth Enhancement Advisory Services LLC lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 80,189 shares of the pharmaceutical coJune 21 at 3:35 AM | marketbeat.comMorgan Stanley Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock PriceMorgan Stanley dropped their target price on Vertex Pharmaceuticals from $464.00 to $460.00 and set an "equal weight" rating on the stock in a research note on Friday.June 20 at 1:54 PM | marketbeat.comCarr Financial Group Corp Acquires New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Carr Financial Group Corp bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 608 shares of the pharmaceutical company's stock, valued atJune 20 at 7:44 AM | marketbeat.comAbundance Wealth Counselors Takes $313,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Abundance Wealth Counselors bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 646 shares of the pharmaceuticaJune 20 at 6:42 AM | marketbeat.comTrifecta Capital Advisors LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Trifecta Capital Advisors LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,538 shares oJune 19 at 8:00 AM | marketbeat.comLion Street Advisors LLC Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Lion Street Advisors LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 594 shares of the pharJune 19 at 4:50 AM | marketbeat.com2 Growth Stocks to Buy and Hold for 10 YearsJune 19 at 4:25 AM | fool.comInscription Capital LLC Acquires Shares of 562 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Inscription Capital LLC acquired a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 562 shares of the pharmaceuJune 19 at 4:21 AM | marketbeat.comTrust Point Inc. Has $212,000 Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Trust Point Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 62.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 437 shares of the pharmaceutical company's stock after selling 738 shares during the period. TJune 19 at 4:02 AM | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Lowered to $420.00 at Royal Bank Of CanadaJune 19 at 1:19 AM | americanbankingnews.comVertex Pharmaceuticals (VRTX) Soared as Investors Back Strategic InitiativesJune 18 at 9:27 AM | insidermonkey.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by State of Alaska Department of RevenueState of Alaska Department of Revenue increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 46,505 shares of the phaJune 18 at 7:00 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Roman Butler Fullerton & Co.Roman Butler Fullerton & Co. boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 97.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,088 shares of the pharmaceutical coJune 18 at 6:11 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Puzo Michael JPuzo Michael J raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,285 shares of the pharmaceutical coJune 18 at 6:10 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Broderick Brian CBroderick Brian C boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,001 shares of the pharmaceuticJune 18 at 5:50 AM | marketbeat.comHemenway Trust Co LLC Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Hemenway Trust Co LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 54,324 shares of the pharmaceJune 18 at 5:31 AM | marketbeat.comProsperity Wealth Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Prosperity Wealth Management Inc. purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,010 shares of the pharmaceutical company's sJune 18 at 5:06 AM | marketbeat.comCENTRAL TRUST Co Lowers Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CENTRAL TRUST Co trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,985 shares of the pharmaceutical company's stock after selling 806 shares during the period.June 18 at 4:58 AM | marketbeat.comQRG Capital Management Inc. Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)QRG Capital Management Inc. grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,393 shares of the pharmaceutical company's stockJune 18 at 4:23 AM | marketbeat.comSowell Financial Services LLC Makes New $1.37 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sowell Financial Services LLC purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,826 shares of tJune 18 at 4:15 AM | marketbeat.comVertex Pharmaceuticals (VRTX) Price Target Slightly Reduced by RBC Capital | VRTX Stock NewsJune 17, 2025 | gurufocus.comRoyal Bank of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $420.00Royal Bank of Canada lowered their price objective on shares of Vertex Pharmaceuticals from $423.00 to $420.00 and set a "sector perform" rating on the stock in a research report on Tuesday.June 17, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Holdings Lowered by Birch Hill Investment Advisors LLCBirch Hill Investment Advisors LLC reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 148,304 shares of the pharmaceutical company's stockJune 17, 2025 | marketbeat.comPKO Investment Management Joint Stock Co Sells 5,800 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)PKO Investment Management Joint Stock Co decreased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 76.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,800 shares of the phJune 17, 2025 | marketbeat.comSagespring Wealth Partners LLC Raises Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sagespring Wealth Partners LLC increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 40.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,230 shares of the pharmaceutical companJune 17, 2025 | marketbeat.comGreat Lakes Retirement Inc. Acquires New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Great Lakes Retirement Inc. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 1,729 shares of the pharmaceutical company's stJune 17, 2025 | marketbeat.comJanney Montgomery Scott LLC Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Janney Montgomery Scott LLC trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.6% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,619 shareJune 17, 2025 | marketbeat.comMission Wealth Management LP Grows Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Mission Wealth Management LP boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,911 shares of the pharmaceutiJune 17, 2025 | marketbeat.comDynamic Advisor Solutions LLC Makes New $1.35 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Dynamic Advisor Solutions LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 2,791 shares of the pharmaceutical company's stock, valued at approximatJune 17, 2025 | marketbeat.comAries Wealth Management Buys New Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Aries Wealth Management acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 605 shares of thJune 16, 2025 | marketbeat.comOptas LLC Has $864,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Optas LLC grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 103.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,782 shares of the pharmaceutical company's stock after purchasing an additionalJune 15, 2025 | marketbeat.comBrighton Jones LLC Purchases 1,994 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Brighton Jones LLC boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 45.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,421 shares of the pharmaceuticJune 15, 2025 | marketbeat.comFoster Victor Wealth Advisors LLC Sells 1,664 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Foster Victor Wealth Advisors LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,924 shares of the pharmaceutical coJune 15, 2025 | marketbeat.comMassachusetts Wealth Management Invests $289,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Massachusetts Wealth Management purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 597 sharesJune 15, 2025 | marketbeat.com3 Monster Stocks to Confidently Own for the Next 10 YearsJune 15, 2025 | 247wallst.comVertex Pharmaceuticals' SWOT analysis: stock poised for growth amid pipeline expansionJune 14, 2025 | investing.comStanley Laman Group Ltd. Buys New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Stanley Laman Group Ltd. acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,002 shares of the phJune 14, 2025 | marketbeat.comVertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should KnowJune 13, 2025 | msn.comOpinicus Capital Inc. Buys Shares of 819 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Opinicus Capital Inc. acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 819 shares of the pharmaceutical company's stocJune 13, 2025 | marketbeat.comCCM Investment Advisers LLC Boosts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CCM Investment Advisers LLC grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 24.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,553 shares of the pharmaceutical company's stJune 13, 2025 | marketbeat.comEverhart Financial Group Inc. Has $1.07 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Everhart Financial Group Inc. boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 33.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,209 shares oJune 13, 2025 | marketbeat.comRMR Wealth Builders Raises Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)RMR Wealth Builders boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,835 shares of the pharmaceuticalJune 13, 2025 | marketbeat.comFerguson Wellman Capital Management Inc. Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Ferguson Wellman Capital Management Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 806 shares of the pJune 13, 2025 | marketbeat.comZhang Financial LLC Trims Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Zhang Financial LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 71.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,316 shares of the pharmaceutical company'June 13, 2025 | marketbeat.comIntegrated Advisors Network LLC Decreases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Integrated Advisors Network LLC decreased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 30.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,156 sharesJune 13, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.240.65▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4229▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRTX Stock Free VRTX Stock Alerts